Daily Dose - Oct 16th, 2026
Daily Dose |
View online
October 16, 2026
Lonza CEO says the CDMO is ‘not in a capacity race’
Wolfgang Wienand said this week that the company is focused on its overall breadth of capabilities, serving customers across scales, regions, and the entire lifecycle.
Read More
Kindeva gets $226M DLA award for nerve agent antidote autoinjectors
The Defense Logistics Agency contract could cover more than three million units manufactured at Kindeva’s St. Louis, Missouri campus.
Read More
Bio-Techne opens GMP small-molecule facility in the UK for cell therapies
The 10,000-square-foot site in Bristol adds cleanroom capacity for cell therapy materials and expands the company’s global manufacturing network.
Read More
